Skip to content
lifestyle.ubi-interactive.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Century Therapeutics, Inc.
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
June 8, 2026
Century Therapeutics Reports First Quarter Financial Results and Business Updates
May 24, 2026
Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions
May 22, 2026
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
March 12, 2026
Century Therapeutics to Participate in Upcoming Investor Conferences in March
February 25, 2026